146 related articles for article (PubMed ID: 15627434)
1. Action of ondansetron and CP-99,994 to modify behavior and antagonize cisplatin-induced emesis in the ferret.
Lau AH; Kan KK; Lai HW; Ngan MP; Rudd JA; Wai MK; Yew DT
Eur J Pharmacol; 2005 Jan; 506(3):241-7. PubMed ID: 15627434
[TBL] [Abstract][Full Text] [Related]
2. Differential action of domperidone to modify emesis and behaviour induced by apomorphine in the ferret.
Lau AH; Ngan MP; Rudd JA; Yew DT
Eur J Pharmacol; 2005 Jun; 516(3):247-52. PubMed ID: 15963978
[TBL] [Abstract][Full Text] [Related]
3. Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret.
Warneck JB; Cheng FH; Barnes MJ; Mills JS; Montana JG; Naylor RJ; Ngan MP; Wai MK; Daiss JO; Tacke R; Rudd JA
Toxicol Appl Pharmacol; 2008 Nov; 232(3):369-75. PubMed ID: 18675289
[TBL] [Abstract][Full Text] [Related]
4. An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret.
Rudd JA; Naylor RJ
Br J Pharmacol; 1996 May; 118(2):209-14. PubMed ID: 8735616
[TBL] [Abstract][Full Text] [Related]
5. Action of ondansetron and CP-99,994 on cisplatin-induced emesis and locomotor activity in Suncus murinus (house musk shrew).
Lau AH; Rudd JA; Yew DT
Behav Pharmacol; 2005 Dec; 16(8):605-12. PubMed ID: 16286811
[TBL] [Abstract][Full Text] [Related]
6. The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret.
Rudd JA; Jordan CC; Naylor RJ
Br J Pharmacol; 1996 Nov; 119(5):931-6. PubMed ID: 8922742
[TBL] [Abstract][Full Text] [Related]
7. Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin.
Rudd JA; Ngan MP; Wai MK; King AG; Witherington J; Andrews PL; Sanger GJ
Neurosci Lett; 2006 Jan; 392(1-2):79-83. PubMed ID: 16182445
[TBL] [Abstract][Full Text] [Related]
8. Differential action of anti-emetic drugs on defecation and emesis induced by prostaglandin E2 in the ferret.
Kan KK; Rudd JA; Wai MK
Eur J Pharmacol; 2006 Aug; 544(1-3):153-9. PubMed ID: 16844111
[TBL] [Abstract][Full Text] [Related]
9. DAT-582, a novel serotonin3 receptor antagonist, is a potent and long-lasting antiemetic agent in the ferret and dog.
Yoshida N; Omoya H; Ito T
J Pharmacol Exp Ther; 1992 Mar; 260(3):1159-65. PubMed ID: 1532032
[TBL] [Abstract][Full Text] [Related]
10. Automated analysis of delayed emesis in the telemetered ferret: detection of synergistic effects of aprepitant and ondansetron.
Goineau S; Guillaume P; Barrais L; Castagné V
Fundam Clin Pharmacol; 2014 Dec; 28(6):643-51. PubMed ID: 24750138
[TBL] [Abstract][Full Text] [Related]
11. The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret.
Tattersall FD; Rycroft W; Hargreaves RJ; Hill RG
Eur J Pharmacol; 1993 Nov; 250(1):R5-6. PubMed ID: 8119305
[TBL] [Abstract][Full Text] [Related]
12. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
[TBL] [Abstract][Full Text] [Related]
13. 5-HT3 receptor antagonists ameliorate emesis in the ferret evoked by neutron or proton radiation.
King GL; Rabin BM; Weatherspoon JK
Aviat Space Environ Med; 1999 May; 70(5):485-92. PubMed ID: 10332945
[TBL] [Abstract][Full Text] [Related]
14. The actions of ondansetron and dexamethasone to antagonise cisplatin-induced emesis in the ferret.
Rudd JA; Naylor RJ
Eur J Pharmacol; 1997 Mar; 322(1):79-82. PubMed ID: 9088874
[TBL] [Abstract][Full Text] [Related]
15. Olvanil: a non-pungent TRPV1 activator has anti-emetic properties in the ferret.
Chu KM; Ngan MP; Wai MK; Yeung CK; Andrews PL; Percie du Sert N; Rudd JA
Neuropharmacology; 2010 Feb; 58(2):383-91. PubMed ID: 19825380
[TBL] [Abstract][Full Text] [Related]
16. Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs.
Yamakuni H; Sawai H; Maeda Y; Imazumi K; Sakuma H; Matsuo M; Mutoh S; Seki J
J Pharmacol Exp Ther; 2000 Mar; 292(3):1002-7. PubMed ID: 10688616
[TBL] [Abstract][Full Text] [Related]
17. Discovery and stereoselective synthesis of the novel isochroman neurokinin-1 receptor antagonist 'CJ-17,493'.
Shishido Y; Wakabayashi H; Koike H; Ueno N; Nukui S; Yamagishi T; Murata Y; Naganeo F; Mizutani M; Shimada K; Fujiwara Y; Sakakibara A; Suga O; Kusano R; Ueda S; Kanai Y; Tsuchiya M; Satake K
Bioorg Med Chem; 2008 Aug; 16(15):7193-205. PubMed ID: 18640044
[TBL] [Abstract][Full Text] [Related]
18. Broad spectrum antiemetic effects of CP-122,721, a tachykinin NK1 receptor antagonist, in ferrets.
Gonsalves S; Watson J; Ashton C
Eur J Pharmacol; 1996 Jun; 305(1-3):181-5. PubMed ID: 8813551
[TBL] [Abstract][Full Text] [Related]
19. Comparison of three preclinical models for nausea and vomiting assessment.
Goineau S; Castagné V
J Pharmacol Toxicol Methods; 2016; 82():45-53. PubMed ID: 27477617
[TBL] [Abstract][Full Text] [Related]
20. Effect of a selective and potent central nervous system penetrant, neurokinin-3 receptor antagonist (SB-222200), on cisplatin-induced emesis in the ferret.
King AG; Sanger GJ
Neurosci Lett; 2005 Mar; 376(1):5-8. PubMed ID: 15694264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
